Related Experiment Video
Updated: Jul 6, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Regression-Based Active Learning for Accessible Acceleration of Ultra-Large Library Docking
Egor Marin1, Margarita Kovaleva1, Maria Kadukova1,2
1Research Center for Molecular Mechanisms of Aging and Age-related Diseases, Moscow Institute of Physics and Technology, Dolgoprudny 141701, Russia.
Active learning with simple models accelerates structure-based drug discovery by significantly reducing computational costs in virtual screening. This approach efficiently identifies high-affinity compounds, making drug discovery more accessible.
Area of Science:
- Computational Chemistry
- Drug Discovery
- Bioinformatics
Background:
- Structure-based drug discovery utilizes 3D biomolecular models for hit identification and optimization.
- Ultralarge virtual screening enables rapid discovery of high-affinity compounds but demands extensive computational resources.
Purpose of the Study:
- To demonstrate that active learning with simple linear regression models can accelerate virtual screening.
- To show that complex models like deep learning are unnecessary for predicting low-sampling-depth docking results.
Main Methods:
- Employed active learning with simple linear regression models for virtual screening.
- Investigated active learning meta-parameters, identifying constant batch size and ensembling as optimal.
- Validated the approach on an ultralarge virtual screening dataset.
Main Results:
- Achieved retrieval of up to 90% of the top-1% docking hits after screening only 10% of ligands.
- Successfully retrieved 70% of the top-0.05% of ligands after screening merely 2% of an ultralarge library.
- Demonstrated the efficacy of simple models over complex deep learning approaches for this task.
Conclusions:
- Active learning with basic models offers a computationally accessible method for accelerated virtual screening.
- This approach can serve as a blueprint for developing low-compute agents for large-scale docking.
- Enhanced accessibility for academic researchers in rapid hit compound discovery for diverse targets.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025